XML 56 R44.htm IDEA: XBRL DOCUMENT v3.19.1
Revenue - Business Revenue (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 30, 2019
Mar. 31, 2018
Mar. 30, 2019
Mar. 31, 2018
Disaggregation of Revenue [Line Items]        
Revenues $ 818.4 $ 789.3 $ 1,649.1 $ 1,580.4
United States        
Disaggregation of Revenue [Line Items]        
Revenues 615.5 588.5 1,237.2 1,185.8
International        
Disaggregation of Revenue [Line Items]        
Revenues 202.9 200.8 411.9 394.6
Diagnostics        
Disaggregation of Revenue [Line Items]        
Revenues 296.7 279.7 593.3 564.3
Diagnostics | United States        
Disaggregation of Revenue [Line Items]        
Revenues 226.8 213.5 454.3 434.7
Diagnostics | International        
Disaggregation of Revenue [Line Items]        
Revenues 69.9 66.2 139.0 129.6
Diagnostics | Cytology & Perinatal        
Disaggregation of Revenue [Line Items]        
Revenues 115.5 117.7 233.6 241.1
Diagnostics | Cytology & Perinatal | United States        
Disaggregation of Revenue [Line Items]        
Revenues 76.6 78.5 155.8 163.2
Diagnostics | Cytology & Perinatal | International        
Disaggregation of Revenue [Line Items]        
Revenues 38.9 39.2 77.8 77.9
Diagnostics | Molecular Diagnostics        
Disaggregation of Revenue [Line Items]        
Revenues 167.8 150.7 332.1 299.3
Diagnostics | Molecular Diagnostics | United States        
Disaggregation of Revenue [Line Items]        
Revenues 136.8 123.7 270.9 247.6
Diagnostics | Molecular Diagnostics | International        
Disaggregation of Revenue [Line Items]        
Revenues 31.0 27.0 61.2 51.7
Diagnostics | Blood Screening        
Disaggregation of Revenue [Line Items]        
Revenues 13.4 11.3 27.6 23.9
Diagnostics | Blood Screening | United States        
Disaggregation of Revenue [Line Items]        
Revenues 13.4 11.3 27.6 23.9
Diagnostics | Blood Screening | International        
Disaggregation of Revenue [Line Items]        
Revenues 0.0 0.0 0.0 0.0
Breast Health        
Disaggregation of Revenue [Line Items]        
Revenues 321.5 300.1 646.2 588.1
Breast Health | United States        
Disaggregation of Revenue [Line Items]        
Revenues 253.0 232.5 505.6 456.9
Breast Health | International        
Disaggregation of Revenue [Line Items]        
Revenues 68.5 67.6 140.6 131.2
Breast Health | Breast Imaging        
Disaggregation of Revenue [Line Items]        
Revenues 265.9 250.4 535.6 486.3
Breast Health | Breast Imaging | United States        
Disaggregation of Revenue [Line Items]        
Revenues 206.2 191.7 412.7 371.5
Breast Health | Breast Imaging | International        
Disaggregation of Revenue [Line Items]        
Revenues 59.7 58.7 122.9 114.8
Breast Health | Interventional Breast Solutions        
Disaggregation of Revenue [Line Items]        
Revenues 55.6 49.7 110.6 101.8
Breast Health | Interventional Breast Solutions | United States        
Disaggregation of Revenue [Line Items]        
Revenues 46.8 40.8 92.9 85.4
Breast Health | Interventional Breast Solutions | International        
Disaggregation of Revenue [Line Items]        
Revenues 8.8 8.9 17.7 16.4
Medical Aesthetics        
Disaggregation of Revenue [Line Items]        
Revenues 73.8 85.5 153.6 176.8
Medical Aesthetics | United States        
Disaggregation of Revenue [Line Items]        
Revenues 37.6 44.4 74.9 91.0
Medical Aesthetics | International        
Disaggregation of Revenue [Line Items]        
Revenues 36.2 41.1 78.7 85.8
GYN Surgical        
Disaggregation of Revenue [Line Items]        
Revenues 102.2 99.4 210.6 206.9
GYN Surgical | United States        
Disaggregation of Revenue [Line Items]        
Revenues 84.1 82.4 175.2 173.9
GYN Surgical | International        
Disaggregation of Revenue [Line Items]        
Revenues 18.1 17.0 35.4 33.0
Skeletal Health        
Disaggregation of Revenue [Line Items]        
Revenues 24.2 24.6 45.4 44.3
Skeletal Health | United States        
Disaggregation of Revenue [Line Items]        
Revenues 14.0 15.7 27.2 29.3
Skeletal Health | International        
Disaggregation of Revenue [Line Items]        
Revenues $ 10.2 $ 8.9 $ 18.2 $ 15.0